✦ LIBER ✦

Long-term survival and morbidity in patients with metastatic malignant germ cell tumors treated with cisplatin-based combination chemotherapy

✍ Scribed by Sophie Dorothea Fosså; Nina Aass; Olav Kaalhus; Olbjørn Klepp; Kjell Tveter

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 557 KB
Volume: 58
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19861215)58:12<2600::aid-cncr2820581208>3.0.co;2-d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term disease-free survival in a chi

Long-term disease-free survival in a child with refractory metastatic malignant germ cell tumor treated by high-dose chemotherapy with autologous bone marrow rescues

✍ Devalck, Christine ;Tempels, Didier ;Ferster, Alina ;De Laet, Marc-Henri ;Bujan, 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

## Abstract We report the case of a 8‐month‐old girl who presented with a metastatic malignant germ cell tumor (MGCT) that proved to be resistant to chemotherapy, including salvage platinum‐based combination therapy, surgery, and metastatectomy. The child was then treated with high‐dose carboplatin

The impact of hydronephrosis on renal fu

The impact of hydronephrosis on renal function in patients treated with cisplatin-based chemotherapy for metastatic nonseminomatous germ cell tumors

✍ C. Barton; G. Duchesne; M. Williams; C. Fisher; A. Horwich 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 546 KB

Long term survival of patients with recu

Long term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy

✍ Jörg Beyer; Dorothea Kingreen; Manuela Krause; Jan Schleicher; Ingo Schwaner; Ni 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

## BACKGROUND. The optimal treatment of patients with recurrent or refractory germ

Improved long term survival of patients

Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era

✍ Dirk J. A. Sonneveld; Harald J. Hoekstra; Winette T. A. van der Graaf; Wim J. Sl 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

Long-term survival in locally advanced o

Long-term survival in locally advanced oral cavity cancer: An analysis of patients treated with neoadjuvant cisplatin-based chemotherapy followed by surgery

✍ Enzo Maria Ruggeri; Paolo Carlini; Camillo Francesco Pollera; Salvatore De Marco 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

## Background: Neoadjuvant chemotherapy has been reported to be extremely active in head and neck cancer but has failed to give a statistically significant improvement in survival. ## Methods: From 1981 to 1994, 33 operable patients with locally advanced oral cavity cancer received cisplatin-base

Cisplatin-based chemotherapy after retro

Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors

✍ Culine, Stéphane; Theodore, Christine; Farhat, Fadi; Bekradda, Mohammed; Terrier 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 1 views

In order to assess the results of cisplatin-based chemotherapy after primary lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors of the testis, we retrospectively reviewed the longterm outcome of 44 patients who received adjuvant chemotherapy at Institut Gus